Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL9GV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,428
Award facts
- Contract value 100% obligated
- $11,427.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,427.82 by the Defense Logistics Agency for the supply of Zepbound 15 mg/0.5 mL pen injections. The contract is a firm fixed price delivery order with an ultimate completion date of November 25, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance of this contract will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Zepbound is a GLP-1 receptor agonist used in diabetes and weight management treatment, reflecting the Defense Logistics Agency's broader mission to supply critical pharmaceuticals and medical commodities to military healthcare systems and beneficiaries. AmerisourceBergen's substantial prime contract with DLA positions it as a key pharmaceutical distributor for federal medical procurement, with demonstrated capability to fulfill diverse therapeutic requirements across multiple domains. The award reinforces the company's role as a critical vendor within the military supply chain, delivering specialized medications to support Defense Health Agency operations and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FL9GV?
SPE2DR26FL9GV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FL9GV worth?
The government has obligated $11,428 on SPE2DR26FL9GV.
Is contract SPE2DR26FL9GV an order under another contract?
Yes. SPE2DR26FL9GV is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9GV competed?
The extent of competition for SPE2DR26FL9GV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award